Somatic NF1 mutational spectrum in benign neurofibromas: MRNA splice defects are common among point mutations

E. Serra, E. Ars, A. Ravella, A. Sánchez, S. Puig, T. Rosenbaum, Xavier P. Estivill, C. Lázaro

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Neurofibromas, benign tumors that originate from the peripheral nerve sheath, are a hallmark of neurofibromatosis type 1 (NF1). Although loss of heterozygosity (LOH) is a common phenomenon in this neoplasia, it only accounts for part of the somatic NF1 mutations found. Somatic point mutations or the presence of "two hits" in the NF1 gene have only been reported for a few neurofibromas. The large size of the NF1 gene together with the multicellular composition of these tumors has greatly hampered their molecular characterization. Here, we present the somatic NF1 mutational analysis of the whole set of neurofibromas studied by our group and consisting in 126 tumors derived from 32 NF1 patients. We report the identification of 45 independent somatic NF1 mutations, 20 of which are reported for the first time. Different types of point mutations together with LOH affecting the NF1 gene and its surrounding region or extending along the 17q arm have been found. Among point mutations, those affecting the correct splicing of the NF1 gene are common, coinciding with results reported on germline NF1 mutations. In most cases, we have been able to confirm that both copies of the NF1 gene are inactivated. We have also found that both somatic and germline mutations can be expressed at the RNA level in the neoplastic cells. Furthermore, we have observed that the study of more than one tumor derived from the same patient is useful for the identification of the germline mutation. Finally, we have noticed that the culture of neurofibromas and their fibroblast clearance facilitates LOH detection in cases in which it is difficult to determine.

Original languageEnglish
Pages (from-to)416-429
Number of pages14
JournalHuman Genetics
Volume108
Issue number5
DOIs
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Neurofibroma
Neurofibromatosis 1
Point Mutation
Neurofibromatosis 1 Genes
Loss of Heterozygosity
Germ-Line Mutation
Mutation
Neoplasms
Nerve Sheath Neoplasms
Fibroblasts
RNA

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Serra, E., Ars, E., Ravella, A., Sánchez, A., Puig, S., Rosenbaum, T., ... Lázaro, C. (2001). Somatic NF1 mutational spectrum in benign neurofibromas: MRNA splice defects are common among point mutations. Human Genetics, 108(5), 416-429. https://doi.org/10.1007/s004390100514

Somatic NF1 mutational spectrum in benign neurofibromas : MRNA splice defects are common among point mutations. / Serra, E.; Ars, E.; Ravella, A.; Sánchez, A.; Puig, S.; Rosenbaum, T.; Estivill, Xavier P.; Lázaro, C.

In: Human Genetics, Vol. 108, No. 5, 2001, p. 416-429.

Research output: Contribution to journalArticle

Serra, E, Ars, E, Ravella, A, Sánchez, A, Puig, S, Rosenbaum, T, Estivill, XP & Lázaro, C 2001, 'Somatic NF1 mutational spectrum in benign neurofibromas: MRNA splice defects are common among point mutations', Human Genetics, vol. 108, no. 5, pp. 416-429. https://doi.org/10.1007/s004390100514
Serra, E. ; Ars, E. ; Ravella, A. ; Sánchez, A. ; Puig, S. ; Rosenbaum, T. ; Estivill, Xavier P. ; Lázaro, C. / Somatic NF1 mutational spectrum in benign neurofibromas : MRNA splice defects are common among point mutations. In: Human Genetics. 2001 ; Vol. 108, No. 5. pp. 416-429.
@article{369c14eae70640af867545759372b3b6,
title = "Somatic NF1 mutational spectrum in benign neurofibromas: MRNA splice defects are common among point mutations",
abstract = "Neurofibromas, benign tumors that originate from the peripheral nerve sheath, are a hallmark of neurofibromatosis type 1 (NF1). Although loss of heterozygosity (LOH) is a common phenomenon in this neoplasia, it only accounts for part of the somatic NF1 mutations found. Somatic point mutations or the presence of {"}two hits{"} in the NF1 gene have only been reported for a few neurofibromas. The large size of the NF1 gene together with the multicellular composition of these tumors has greatly hampered their molecular characterization. Here, we present the somatic NF1 mutational analysis of the whole set of neurofibromas studied by our group and consisting in 126 tumors derived from 32 NF1 patients. We report the identification of 45 independent somatic NF1 mutations, 20 of which are reported for the first time. Different types of point mutations together with LOH affecting the NF1 gene and its surrounding region or extending along the 17q arm have been found. Among point mutations, those affecting the correct splicing of the NF1 gene are common, coinciding with results reported on germline NF1 mutations. In most cases, we have been able to confirm that both copies of the NF1 gene are inactivated. We have also found that both somatic and germline mutations can be expressed at the RNA level in the neoplastic cells. Furthermore, we have observed that the study of more than one tumor derived from the same patient is useful for the identification of the germline mutation. Finally, we have noticed that the culture of neurofibromas and their fibroblast clearance facilitates LOH detection in cases in which it is difficult to determine.",
author = "E. Serra and E. Ars and A. Ravella and A. S{\'a}nchez and S. Puig and T. Rosenbaum and Estivill, {Xavier P.} and C. L{\'a}zaro",
year = "2001",
doi = "10.1007/s004390100514",
language = "English",
volume = "108",
pages = "416--429",
journal = "Human Genetics",
issn = "0340-6717",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Somatic NF1 mutational spectrum in benign neurofibromas

T2 - MRNA splice defects are common among point mutations

AU - Serra, E.

AU - Ars, E.

AU - Ravella, A.

AU - Sánchez, A.

AU - Puig, S.

AU - Rosenbaum, T.

AU - Estivill, Xavier P.

AU - Lázaro, C.

PY - 2001

Y1 - 2001

N2 - Neurofibromas, benign tumors that originate from the peripheral nerve sheath, are a hallmark of neurofibromatosis type 1 (NF1). Although loss of heterozygosity (LOH) is a common phenomenon in this neoplasia, it only accounts for part of the somatic NF1 mutations found. Somatic point mutations or the presence of "two hits" in the NF1 gene have only been reported for a few neurofibromas. The large size of the NF1 gene together with the multicellular composition of these tumors has greatly hampered their molecular characterization. Here, we present the somatic NF1 mutational analysis of the whole set of neurofibromas studied by our group and consisting in 126 tumors derived from 32 NF1 patients. We report the identification of 45 independent somatic NF1 mutations, 20 of which are reported for the first time. Different types of point mutations together with LOH affecting the NF1 gene and its surrounding region or extending along the 17q arm have been found. Among point mutations, those affecting the correct splicing of the NF1 gene are common, coinciding with results reported on germline NF1 mutations. In most cases, we have been able to confirm that both copies of the NF1 gene are inactivated. We have also found that both somatic and germline mutations can be expressed at the RNA level in the neoplastic cells. Furthermore, we have observed that the study of more than one tumor derived from the same patient is useful for the identification of the germline mutation. Finally, we have noticed that the culture of neurofibromas and their fibroblast clearance facilitates LOH detection in cases in which it is difficult to determine.

AB - Neurofibromas, benign tumors that originate from the peripheral nerve sheath, are a hallmark of neurofibromatosis type 1 (NF1). Although loss of heterozygosity (LOH) is a common phenomenon in this neoplasia, it only accounts for part of the somatic NF1 mutations found. Somatic point mutations or the presence of "two hits" in the NF1 gene have only been reported for a few neurofibromas. The large size of the NF1 gene together with the multicellular composition of these tumors has greatly hampered their molecular characterization. Here, we present the somatic NF1 mutational analysis of the whole set of neurofibromas studied by our group and consisting in 126 tumors derived from 32 NF1 patients. We report the identification of 45 independent somatic NF1 mutations, 20 of which are reported for the first time. Different types of point mutations together with LOH affecting the NF1 gene and its surrounding region or extending along the 17q arm have been found. Among point mutations, those affecting the correct splicing of the NF1 gene are common, coinciding with results reported on germline NF1 mutations. In most cases, we have been able to confirm that both copies of the NF1 gene are inactivated. We have also found that both somatic and germline mutations can be expressed at the RNA level in the neoplastic cells. Furthermore, we have observed that the study of more than one tumor derived from the same patient is useful for the identification of the germline mutation. Finally, we have noticed that the culture of neurofibromas and their fibroblast clearance facilitates LOH detection in cases in which it is difficult to determine.

UR - http://www.scopus.com/inward/record.url?scp=0035007009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035007009&partnerID=8YFLogxK

U2 - 10.1007/s004390100514

DO - 10.1007/s004390100514

M3 - Article

C2 - 11409870

AN - SCOPUS:0035007009

VL - 108

SP - 416

EP - 429

JO - Human Genetics

JF - Human Genetics

SN - 0340-6717

IS - 5

ER -